Join Now

Yearly Archives: 2021

Clene Nanomedicine to Present RESCUE-ALS Phase 2 Data in Late-Breaking Session at 32nd International Symposium on ALS/MND

Clene presented data from the RESCUE-ALS Phase 2 study of CNM-Au8®, a catalytically active gold nanocrystal suspension, for the treatment of amyotrophic lateral sclerosis (ALS).

Posted in BioUtah News | Tagged | Leave a comment

Pfizer to Acquire Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. and Pfizer Inc. have entered into a definitive agreement under which Pfizer will acquire Arena.

Posted in BioUtah News | Tagged | Leave a comment

IONIQ’s breast cancer feasibility results published by IEEE

Salt Lake City, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc. (“IONIQ” or the “Company”), is proud to announce the prestigious IEEE Access peer-reviewed journal has published a scientific manuscript on the life-saving potential of our ‘breakthrough’ bioimpedance technology in breast cancer. “Skin Electrical Resistance as a Diagnostic […]

Posted in BioUtah News | Leave a comment

Recursion loops in Roche, Genentech for multibillion-dollar AI drug discovery deal

The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division.

Posted in BioUtah News | Tagged | Leave a comment

ARUP Laboratories Earns Fourth Consecutive Utah Business Best Companies To Work For Award

For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award.

Posted in BioUtah News | Tagged | Leave a comment

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022

Renalytix reported financial results for the quarter ended September 30, 2021.

Posted in BioUtah News | Tagged | Leave a comment

Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology

The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery

Posted in BioUtah News | Tagged | Leave a comment

Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities

Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test

Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD).

Posted in BioUtah News | Tagged , | Leave a comment

Foldax Receives Approval for Clinical Trial of TRIA Biopolymer Surgical Aortic Heart Valve in India

Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.

Posted in BioUtah News | Tagged | Leave a comment

HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler

Collaboration Expands Clinical Sites for Trial

Posted in BioUtah News | Tagged | Leave a comment

Courts Halt Two Biden Vaccine Mandates

In two separate rulings on Tuesday, federal judges temporarily halted the Biden Administration’s COVID-19 vaccine mandates for healthcare workers and federal contractors. One ruling, in a Missouri federal district court, prohibits CMS from enforcing its COVID-19 vaccine mandate in Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. A second […]

Posted in Policy News | Leave a comment